- Home
- BFRI vs QNTM Comparison
BFRI vs QNTM Comparison
Compare BFRI & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- QNTM
- Stock Information
- Founded
- BFRI 1997
- QNTM 1998
- Country
- BFRI United States
- QNTM Canada
- Employees
- BFRI N/A
- QNTM N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- QNTM
- Sector
- BFRI Health Care
- QNTM
- Exchange
- BFRI Nasdaq
- QNTM NYSE
- Market Cap
- BFRI 8.7M
- QNTM 8.7M
- IPO Year
- BFRI 2021
- QNTM N/A
- Fundamental
- Price
- BFRI $0.80
- QNTM $8.01
- Analyst Decision
- BFRI Strong Buy
- QNTM
- Analyst Count
- BFRI 1
- QNTM 0
- Target Price
- BFRI $7.00
- QNTM N/A
- AVG Volume (30 Days)
- BFRI 90.7K
- QNTM 1.5M
- Earning Date
- BFRI 03-21-2025
- QNTM 05-13-2025
- Dividend Yield
- BFRI N/A
- QNTM N/A
- EPS Growth
- BFRI N/A
- QNTM N/A
- EPS
- BFRI N/A
- QNTM N/A
- Revenue
- BFRI $37,321,000.00
- QNTM N/A
- Revenue This Year
- BFRI $28.62
- QNTM N/A
- Revenue Next Year
- BFRI $27.07
- QNTM N/A
- P/E Ratio
- BFRI N/A
- QNTM N/A
- Revenue Growth
- BFRI 9.54
- QNTM N/A
- 52 Week Low
- BFRI $0.65
- QNTM $2.70
- 52 Week High
- BFRI $2.43
- QNTM $46.80
- Technical
- Relative Strength Index (RSI)
- BFRI 34.75
- QNTM 59.20
- Support Level
- BFRI $0.81
- QNTM $6.45
- Resistance Level
- BFRI $0.96
- QNTM $12.45
- Average True Range (ATR)
- BFRI 0.08
- QNTM 1.59
- MACD
- BFRI -0.01
- QNTM 0.30
- Stochastic Oscillator
- BFRI 8.79
- QNTM 43.40
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.